By Dr. Betty Martini
Mission Possible International
Mission Possible is seeking New York and New Jersey plaintiffs for litigation on aspartame.
ATLANTA (PRWEB) April 12, 2005 -- Consumer rights advocacy group Mission Possible is leading a campaign to fill a product liability lawsuit with New York and New Jersey residents whose brain tumors may be linked to the consumption of the artificial sweetener aspartame (NutraSweet/Equal/Spoonful, etc.).
"Neither congressional hearings or repeated petitions calling for a ban have stopped aspartame manufacturers from exposing the public to this sweet poison. In fact, aspartame producers are reporting increased sales and boasting the marketplace addition of 'neotame,' a new aspartame product," explained Mission Possible International Founder Betty Martini.
For 16 years, the FDA resisted pressure to approve aspartame due to safety studies linking the artificial sweetener to numerous adverse reactions, including the development of brain tumors in animal studies. In 1977, FDA investigator Jerome Bressler released a report describing how, in clinical studies submitted to the FDA, Searle removed aspartame-induced brain tumors that developed in lab rats and placed them back into the study. If the rats died, Bressler reported, Searle would resurrect them on paper.